A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.
Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D; Efalizumab Study Group.
Lebwohl M, et al. Among authors: hamilton tk.
N Engl J Med. 2003 Nov 20;349(21):2004-13. doi: 10.1056/NEJMoa030002.
N Engl J Med. 2003.
PMID: 14627785
Free article.
Clinical Trial.